Boufenzer, Amir
Carrasco, Kevin
Jolly, Lucie
Brustolin, Benjamin
Di-Pillo, Elisa
Derive, Marc
Gibot, Sébastien
Article History
Received: 25 May 2020
Accepted: 8 November 2020
First Online: 8 January 2021
Competing interests
: SG and MD are co-founder of INOTREM, a company that develops TREM-1 inhibitors. AB, KC, LJ, and MD are employed by INOTREM. The remaining authors declare that they have no competing interests.